Litcius/Paper detail

18F-PSMA-11 Versus 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography for Staging and Biochemical Recurrence of Prostate Cancer: A Prospective Double-blind Randomised Cross-over Trial

Kathia De Man, Nick Van Laeken, Vanessa Schelfhout, Wolfgang P. Fendler, Bieke Lambert, Ken Kersemans, Sarah Piron, Nicolaas Lumen, Karel Decaestecker, Valérie Fonteyne, Louke Delrue, Filip De Vos, Piet Ost

2022European Urology37 citationsDOI

Topics & Concepts

MedicineGlutamate carboxypeptidase IIProstate cancerPositron emission tomographyPositron Emission Tomography-Computed TomographyNuclear medicineBiochemical recurrenceClinical endpointProspective cohort studyProstateRadiologyPET-CTClinical trialCancerInternal medicineProstatectomyProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentRadiopharmaceutical Chemistry and Applications
18F-PSMA-11 Versus 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography for Staging and Biochemical Recurrence of Prostate Cancer: A Prospective Double-blind Randomised Cross-over Trial | Litcius